A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...

An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea ... a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free ...

A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first ...

4, 2025 — Research has shown that a potential new targeted therapy for childhood brain ... 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window After HHS ...

Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...